2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neuroendocrine Tumors
12
Neoplasms
8
Carcinoid Tumor
7
Diarrhea
6
Colorectal Neoplasms
6
Carcinoma, Hepatocellular
6
Breast Neoplasms
5
Acromegaly
5
Vipoma
4
Stomach Neoplasms
4
Somatostatinoma
4
Rectal Neoplasms
4
Insulinoma
4
Glucagonoma
4
Gastro-enteropancreatic neuroendocrine tumor
4
Esophageal Neoplasms
4
Carcinoma, Islet Cell
4
Adenoma, Islet Cell
4
Weight Loss
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Intestinal Obstruction
3
Gastrinoma
3
Colonic Neoplasms
3
Carcinoma
3
Thymoma
2
Pituitary Neoplasms
2
Ovarian Neoplasms
2
Meningioma
2
Interventions
exemestane
1
Therapeutics
1
Tamoxifen
1
Sulfasalazine
1
Saline Solution
1
Preoperative Exercise
1
Oxycodone
1
Olanzapine
1
Octreotide
1
Nutrition Therapy
1
Megestrol Acetate
1
Diet Therapy
1
Anastrozole
1
Anastomosis, Roux-en-Y
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Nutrition Disorders
×
Octreotide
×
Clear all
NCT03734627
2021-08-16
EndoGut
St. James's Hospital, Ireland
Completed
40 enrolled